BORTEZOMIB TEVA 1 MG

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

BORTEZOMIB

Saatavilla:

ABIC MARKETING LTD, ISRAEL

ATC-koodi:

L01XX32

Lääkemuoto:

POWDER FOR SOLUTION FOR INJECTION

Koostumus:

BORTEZOMIB 1 MG

Antoreitti:

I.V

Prescription tyyppi:

Required

Valmistaja:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Terapeuttinen alue:

BORTEZOMIB

Käyttöaiheet:

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Valtuutus päivämäärä:

2017-07-04